About CLS
News and insights
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2
Treating severe diseases as cancer in a precise and careful way is CLS’ driving force. Our exciting journey has started and we are continuously adding new skills and energy to our dynamic team. Do not hesitate to send in your CV to register your interest to our HR manager. When you submit your CV, you also give your consent according to our GDPR policy. You can contact us at any time and request that we delete your personal information.
The Holiday Season is approaching, and the CLS team wishes our shareholders, collaboration partners, clinicians & patients a Merry Christmas and a Happy New Year!
Last week we joined the 2024 Congress of Neurological Surgeons (CNS) meeting in Houston where our partner ClearPoint Neuro, Inc. exhibited the ClearPoint Prism® Neuro Laser Therapy System, powered by CLS. In addition to good booth traffic and customer discussions, we also took part in the scientific program providing the latest updates on the use of Laser Interstitial Thermal Therapy (LITT) in neurosurgery.
Both abstracts provide the latest insights into the clinical use of focal laser ablation for prostate cancer, contributing to the ongoing development of minimally invasive cancer therapies.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2